Intellia Therapeutics Inc (NTLA)
23.60
+0.33
(+1.42%)
USD |
NASDAQ |
May 03, 16:00
23.59
-0.01
(-0.04%)
After-Hours: 20:00
Intellia Therapeutics Free Cash Flow (Quarterly): -94.57M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -94.57M |
September 30, 2023 | -105.71M |
June 30, 2023 | -94.62M |
March 31, 2023 | -113.16M |
December 31, 2022 | -93.78M |
September 30, 2022 | -82.76M |
June 30, 2022 | -89.07M |
March 31, 2022 | -126.06M |
December 31, 2021 | -57.52M |
September 30, 2021 | -69.56M |
June 30, 2021 | -55.92M |
March 31, 2021 | -54.79M |
December 31, 2020 | -41.23M |
September 30, 2020 | -29.26M |
June 30, 2020 | 56.38M |
March 31, 2020 | -39.39M |
December 31, 2019 | -31.23M |
September 30, 2019 | -27.20M |
Date | Value |
---|---|
June 30, 2019 | -28.62M |
March 31, 2019 | -22.99M |
December 31, 2018 | -10.13M |
September 30, 2018 | -14.47M |
June 30, 2018 | -23.40M |
March 31, 2018 | -19.62M |
December 31, 2017 | -23.70M |
September 30, 2017 | -19.15M |
June 30, 2017 | -16.95M |
March 31, 2017 | -15.56M |
December 31, 2016 | -17.82M |
September 30, 2016 | -8.215M |
June 30, 2016 | 66.40M |
March 31, 2016 | -10.43M |
December 31, 2015 | -6.34M |
September 30, 2015 | -3.869M |
June 30, 2015 | 1.586M |
March 31, 2015 | 4.306M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-126.06M
Minimum
Mar 2022
56.38M
Maximum
Jun 2020
-62.00M
Average
-57.52M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
Moderna Inc | -1.185B |
Regeneron Pharmaceuticals Inc | 1.351B |
NeuroMetrix Inc | -1.496M |
Repligen Corp | 36.34M |
Pacific Biosciences of California Inc | -59.58M |